Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Post by rex50on Aug 10, 2015 4:23pm

150 Views

Post# 24004566

Profit surge

From Q4 2014 to Q1 2015 salespersons changed from 15 to 20, number of hospitals using Aggrastat increased from 190 to 240 and revenue increased from 2.49 million to 3.34 millions. Such drastic improvement for subsequent quarter bodes well for Q2 and subsequent quarters as management continue to promise increasing revenue for several quarters. Almost all revenue is RECURRING and most expenses in Canadian $ while all revenue is in surging US $. Two quarters from now one can expect 15 to 20 cents Quarterly EPS imo.

Bullboard Posts

Catch up with companies that got a Stanley Cup Playoffs boost